- $22.07m
- $1.32m
Annual balance sheet for KALA BIO, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 154 | 92.1 | 70.5 | 50.9 | 51.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9.85 | 17.5 | 1.1 | 0.236 | — |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 171 | 124 | 85.9 | 52.9 | 52.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 31 | 4.02 | 0.416 | 2.78 | 2.44 |
Other Long Term Assets | |||||
Total Assets | 222 | 139 | 86.8 | 55.9 | 55.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 22.2 | 37.4 | 25.7 | 8.35 | 17 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 122 | 123 | 67.8 | 48.4 | 43.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 100 | 16.8 | 19 | 7.5 | 12.3 |
Total Liabilities & Shareholders' Equity | 222 | 139 | 86.8 | 55.9 | 55.5 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |